Who is sponsoring NCT07528170?

NCT07528170 is sponsored by St. Olavs Hospital.

What drugs are being tested in NCT07528170?

Interventions in NCT07528170: CT-guided needle biopsy of lung nodule.

What condition does NCT07528170 study?

NCT07528170 studies Pneumothorax Iatrogenic Postprocedural, Air Embolism as A Complication of Medical Care, Hemoptysis.

Is NCT07528170 still recruiting?

NCT07528170 is currently completed. Last updated 14 April 2026.

Last reviewed 2026-04-14 · How we verify

NCT07528170: KELSO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Complications After CT-guided Lung Biopsies at St. Olavs Hospital

Completed Last updated 14 April 2026

What this trial tests

trial testing CT-guided needle biopsy of lung nodule in Pneumothorax Iatrogenic Postprocedural in 1,200 participants. Completed in 31 December 2023.

Timeline

1 May 2012

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	St. Olavs Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,200
Start date	1 May 2012
Primary completion	31 December 2023
Estimated completion	31 December 2023

Drugs / interventions tested

CT-guided needle biopsy of lung nodule

Conditions studied

Pneumothorax Iatrogenic Postprocedural — all drugs for Pneumothorax Iatrogenic Postprocedural →
Air Embolism as A Complication of Medical Care — all drugs for Air Embolism as A Complication of Medical Care →
Hemoptysis — all drugs for Hemoptysis →

Sponsor

St. Olavs Hospital

Who can join

Eligibility, any sex, with Pneumothorax Iatrogenic Postprocedural or Air Embolism as A Complication of Medical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other St. Olavs Hospital trials

Trials by the same sponsor.

NCT07331766 — Collaboratory Treatment Pathway for Chronic Pain Patients. · NA · enrolling by invitation
NCT07305025 — Pelvic Pain Electro-Acupuncture · NA · not yet recruiting
NCT07245264 — Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH) · Phase 2, PHASE3 · recruiting
NCT07180433 — Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer · NA · not yet recruiting
NCT06854861 — Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes · Phase 1, PHASE2 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07528170 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Olavs Hospital
Last refreshed: 14 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07528170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing